Performance in the first half of the quarter was impacted by a cluster of companies with over 10% stock price moves. Read ...

Reshape Lifesciences RSLS stock moved upwards by 81.6% to $0.62 during Thursday's regular session. The market value of their outstanding shares is at $2.0 million. As per ...

RBC Capital lowered the firm’s price target on Bio-Rad (BIO) to $409 from $430 and keeps an Outperform rating on the shares as part of a ...